Global and Japan Weight Loss Drugs Market Insights, Forecast to 2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 144
Inquire Before Buying

Weight Loss Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Weight Loss Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Weight Loss Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Liauid Weight Loss Drugs

- Tablets Weight Loss Drugs

Segment by Application

- Weight-reducing Aid

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Roche

- GSK group

- Teva

- Sandoz(Novartis)

- STADA-VN J.V.Co., Ltd

- Hexal AG

- National Company For Pharmaceutical Industry

- Lunan Pharmaceutical Group Corporation

- Zein Pharmaceutical

- Hisun

- Taj Pharmaceuticals Ltd

- Kabir Life Sciences & Research

- Dm Pharma

- China Zhongshan Pharm

Global and Japan Weight Loss Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Weight Loss Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Weight Loss Drugs Market Size Growth Rate by Type
1.2.2 Liauid Weight Loss Drugs
1.2.3 Tablets Weight Loss Drugs
1.3 Market by Application
1.3.1 Global Weight Loss Drugs Market Size Growth Rate by Application
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Weight Loss Drugs Market Size, Estimates and Forecasts
2.1.1 Global Weight Loss Drugs Revenue 2016-2027
2.1.2 Global Weight Loss Drugs Sales 2016-2027
2.2 Global Weight Loss Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Weight Loss Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Weight Loss Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Weight Loss Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Weight Loss Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Weight Loss Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Weight Loss Drugs Revenue Forecast by Region (2022-2027)
3 Global Weight Loss Drugs Competitor Landscape by Players
3.1 Global Top Weight Loss Drugs Manufacturers by Sales
3.1.1 Global Weight Loss Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Weight Loss Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Weight Loss Drugs Manufacturers by Revenue
3.2.1 Key Weight Loss Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Weight Loss Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Weight Loss Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Weight Loss Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Weight Loss Drugs Revenue in 2020
3.2.6 Global Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Weight Loss Drugs Price by Manufacturers
3.4 Global Weight Loss Drugs Manufacturing Base Distribution, Product Types
3.4.1 Weight Loss Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Weight Loss Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Weight Loss Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Weight Loss Drugs Market Size by Type (2016-2021)
4.1.1 Global Weight Loss Drugs Sales by Type (2016-2021)
4.1.2 Global Weight Loss Drugs Revenue by Type (2016-2021)
4.1.3 Weight Loss Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Weight Loss Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Weight Loss Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Weight Loss Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Weight Loss Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Weight Loss Drugs Market Size by Application (2016-2021)
5.1.1 Global Weight Loss Drugs Sales by Application (2016-2021)
5.1.2 Global Weight Loss Drugs Revenue by Application (2016-2021)
5.1.3 Weight Loss Drugs Price by Application (2016-2021)
5.2 Weight Loss Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Weight Loss Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Weight Loss Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Weight Loss Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Weight Loss Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Weight Loss Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Weight Loss Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Weight Loss Drugs Market Share in Global Market 2016-2027
6.2 Japan Weight Loss Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Weight Loss Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Weight Loss Drugs Players by Revenue (2016-2021)
6.3 Japan Weight Loss Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Weight Loss Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Weight Loss Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Weight Loss Drugs Price by Type (2016-2021)
6.4 Japan Weight Loss Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Weight Loss Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Weight Loss Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Weight Loss Drugs Price Forecast by Type (2022-2027)
6.5 Japan Weight Loss Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Weight Loss Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Weight Loss Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Weight Loss Drugs Price by Application (2016-2021)
6.6 Japan Weight Loss Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Weight Loss Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Weight Loss Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Weight Loss Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Weight Loss Drugs Market Size YoY Growth 2016-2027
7.2 North America Weight Loss Drugs Market Facts & Figures by Country
7.2.1 North America Weight Loss Drugs Sales by Country (2016-2021)
7.2.2 North America Weight Loss Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Weight Loss Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Weight Loss Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Weight Loss Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Weight Loss Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Weight Loss Drugs Market Size YoY Growth 2016-2027
9.2 Europe Weight Loss Drugs Market Facts & Figures by Country
9.2.1 Europe Weight Loss Drugs Sales by Country (2016-2021)
9.2.2 Europe Weight Loss Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Weight Loss Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Weight Loss Drugs Market Facts & Figures by Country
10.2.1 Latin America Weight Loss Drugs Sales by Country (2016-2021)
10.2.2 Latin America Weight Loss Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Weight Loss Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Weight Loss Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Weight Loss Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Weight Loss Drugs Products Offered
12.1.5 Roche Recent Development
12.2 GSK group
12.2.1 GSK group Corporation Information
12.2.2 GSK group Description and Business Overview
12.2.3 GSK group Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK group Weight Loss Drugs Products Offered
12.2.5 GSK group Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Weight Loss Drugs Products Offered
12.3.5 Teva Recent Development
12.4 Sandoz(Novartis)
12.4.1 Sandoz(Novartis) Corporation Information
12.4.2 Sandoz(Novartis) Description and Business Overview
12.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sandoz(Novartis) Weight Loss Drugs Products Offered
12.4.5 Sandoz(Novartis) Recent Development
12.5 STADA-VN J.V.Co., Ltd
12.5.1 STADA-VN J.V.Co., Ltd Corporation Information
12.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
12.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 STADA-VN J.V.Co., Ltd Weight Loss Drugs Products Offered
12.5.5 STADA-VN J.V.Co., Ltd Recent Development
12.6 Hexal AG
12.6.1 Hexal AG Corporation Information
12.6.2 Hexal AG Description and Business Overview
12.6.3 Hexal AG Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hexal AG Weight Loss Drugs Products Offered
12.6.5 Hexal AG Recent Development
12.7 National Company For Pharmaceutical Industry
12.7.1 National Company For Pharmaceutical Industry Corporation Information
12.7.2 National Company For Pharmaceutical Industry Description and Business Overview
12.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 National Company For Pharmaceutical Industry Weight Loss Drugs Products Offered
12.7.5 National Company For Pharmaceutical Industry Recent Development
12.8 Lunan Pharmaceutical Group Corporation
12.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
12.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
12.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Products Offered
12.8.5 Lunan Pharmaceutical Group Corporation Recent Development
12.9 Zein Pharmaceutical
12.9.1 Zein Pharmaceutical Corporation Information
12.9.2 Zein Pharmaceutical Description and Business Overview
12.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zein Pharmaceutical Weight Loss Drugs Products Offered
12.9.5 Zein Pharmaceutical Recent Development
12.10 Hisun
12.10.1 Hisun Corporation Information
12.10.2 Hisun Description and Business Overview
12.10.3 Hisun Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisun Weight Loss Drugs Products Offered
12.10.5 Hisun Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Weight Loss Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Kabir Life Sciences & Research
12.12.1 Kabir Life Sciences & Research Corporation Information
12.12.2 Kabir Life Sciences & Research Description and Business Overview
12.12.3 Kabir Life Sciences & Research Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kabir Life Sciences & Research Products Offered
12.12.5 Kabir Life Sciences & Research Recent Development
12.13 Dm Pharma
12.13.1 Dm Pharma Corporation Information
12.13.2 Dm Pharma Description and Business Overview
12.13.3 Dm Pharma Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dm Pharma Products Offered
12.13.5 Dm Pharma Recent Development
12.14 China Zhongshan Pharm
12.14.1 China Zhongshan Pharm Corporation Information
12.14.2 China Zhongshan Pharm Description and Business Overview
12.14.3 China Zhongshan Pharm Weight Loss Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 China Zhongshan Pharm Products Offered
12.14.5 China Zhongshan Pharm Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Weight Loss Drugs Industry Trends
13.2 Weight Loss Drugs Market Drivers
13.3 Weight Loss Drugs Market Challenges
13.4 Weight Loss Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Weight Loss Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Weight Loss Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liauid Weight Loss Drugs
Table 3. Major Manufacturers of Tablets Weight Loss Drugs
Table 4. Global Weight Loss Drugs Market Size Growth Rate by Application (2021-2027) & (K Tablets)
Table 5. Global Weight Loss Drugs Market Size by Region (K Tablets) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Weight Loss Drugs Sales by Regions (2016-2021) & (K Tablets)
Table 7. Global Weight Loss Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Weight Loss Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Weight Loss Drugs Sales Forecast by Region (2022-2027) & (K Tablets)
Table 10. Global Weight Loss Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Weight Loss Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Weight Loss Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Weight Loss Drugs Sales by Manufacturers (2016-2021) (K Tablets)
Table 14. Global Weight Loss Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Weight Loss Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Weight Loss Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Weight Loss Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Weight Loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Weight Loss Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Drugs as of 2020)
Table 20. Key Manufacturers Weight Loss Drugs Price (2016-2021) (USD/Tablet)
Table 21. Weight Loss Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Weight Loss Drugs Product Type
Table 23. Date of International Manufacturers Enter into Weight Loss Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Weight Loss Drugs Sales by Type (2016-2021) (K Tablets)
Table 26. Global Weight Loss Drugs Sales Share by Type (2016-2021)
Table 27. Global Weight Loss Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Weight Loss Drugs Revenue Share by Type (2016-2021)
Table 29. Weight Loss Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Tablet)
Table 30. Global Weight Loss Drugs Sales Forecast by Type (2022-2027) & (K Tablets)
Table 31. Global Weight Loss Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Weight Loss Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Weight Loss Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Weight Loss Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Tablet)
Table 35. Global Weight Loss Drugs Sales by Application (2016-2021) (K Tablets)
Table 36. Global Weight Loss Drugs Sales Share by Application (2016-2021)
Table 37. Global Weight Loss Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Weight Loss Drugs Revenue Share by Application (2016-2021)
Table 39. Weight Loss Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Tablet)
Table 40. Global Weight Loss Drugs Sales Forecast by Application (2022-2027) & (K Tablets)
Table 41. Global Weight Loss Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Weight Loss Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Weight Loss Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Weight Loss Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Tablet)
Table 45. Japan Weight Loss Drugs Sales (K Tablets) of Key Companies (2016-2021)
Table 46. Japan Weight Loss Drugs Sales Share by Company (2016-2021)
Table 47. Japan Weight Loss Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Weight Loss Drugs Revenue Share by Company (2016-2021)
Table 49. Japan Weight Loss Drugs Sales (K Tablets) by Type (2016-2021)
Table 50. Japan Weight Loss Drugs Sales Share by Type (2016-2021)
Table 51. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Weight Loss Drugs Price (USD/Tablet) by Type (2016-2021)
Table 53. Japan Weight Loss Drugs Sales (K Tablets) by Type (2022-2027)
Table 54. Japan Weight Loss Drugs Sales Share by Type (2022-2027)
Table 55. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Weight Loss Drugs Revenue Share by Type (2022-2027)
Table 57. Japan Weight Loss Drugs Price (USD/Tablet) by Type (2022-2027)
Table 58. Japan Weight Loss Drugs Sales (K Tablets) by Application (2016-2021)
Table 59. Japan Weight Loss Drugs Sales Share by Application (2016-2021)
Table 60. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Weight Loss Drugs Price (USD/Tablet) by Application (2016-2021)
Table 62. Japan Weight Loss Drugs Sales (K Tablets) by Application (2022-2027)
Table 63. Japan Weight Loss Drugs Sales Share by Application (2022-2027)
Table 64. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Weight Loss Drugs Revenue Share by Application (2022-2027)
Table 66. Japan Weight Loss Drugs Price (USD/Tablet) by Application (2022-2027)
Table 67. North America Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 68. North America Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Weight Loss Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Weight Loss Drugs Sales by Region (2016-2021) & (K Tablets)
Table 72. Asia Pacific Weight Loss Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Weight Loss Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Weight Loss Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 76. Europe Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Weight Loss Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 80. Latin America Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Weight Loss Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 84. Middle East and Africa Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Weight Loss Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 87. Roche Corporation Information
Table 88. Roche Description and Business Overview
Table 89. Roche Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 90. Roche Weight Loss Drugs Product
Table 91. Roche Recent Development
Table 92. GSK group Corporation Information
Table 93. GSK group Description and Business Overview
Table 94. GSK group Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 95. GSK group Product
Table 96. GSK group Recent Development
Table 97. Teva Corporation Information
Table 98. Teva Description and Business Overview
Table 99. Teva Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 100. Teva Product
Table 101. Teva Recent Development
Table 102. Sandoz(Novartis) Corporation Information
Table 103. Sandoz(Novartis) Description and Business Overview
Table 104. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 105. Sandoz(Novartis) Product
Table 106. Sandoz(Novartis) Recent Development
Table 107. STADA-VN J.V.Co., Ltd Corporation Information
Table 108. STADA-VN J.V.Co., Ltd Description and Business Overview
Table 109. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 110. STADA-VN J.V.Co., Ltd Product
Table 111. STADA-VN J.V.Co., Ltd Recent Development
Table 112. Hexal AG Corporation Information
Table 113. Hexal AG Description and Business Overview
Table 114. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 115. Hexal AG Product
Table 116. Hexal AG Recent Development
Table 117. National Company For Pharmaceutical Industry Corporation Information
Table 118. National Company For Pharmaceutical Industry Description and Business Overview
Table 119. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 120. National Company For Pharmaceutical Industry Product
Table 121. National Company For Pharmaceutical Industry Recent Development
Table 122. Lunan Pharmaceutical Group Corporation Corporation Information
Table 123. Lunan Pharmaceutical Group Corporation Description and Business Overview
Table 124. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 125. Lunan Pharmaceutical Group Corporation Product
Table 126. Lunan Pharmaceutical Group Corporation Recent Development
Table 127. Zein Pharmaceutical Corporation Information
Table 128. Zein Pharmaceutical Description and Business Overview
Table 129. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 130. Zein Pharmaceutical Product
Table 131. Zein Pharmaceutical Recent Development
Table 132. Hisun Corporation Information
Table 133. Hisun Description and Business Overview
Table 134. Hisun Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 135. Hisun Product
Table 136. Hisun Recent Development
Table 137. Taj Pharmaceuticals Ltd Corporation Information
Table 138. Taj Pharmaceuticals Ltd Description and Business Overview
Table 139. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 140. Taj Pharmaceuticals Ltd Product
Table 141. Taj Pharmaceuticals Ltd Recent Development
Table 142. Kabir Life Sciences & Research Corporation Information
Table 143. Kabir Life Sciences & Research Description and Business Overview
Table 144. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 145. Kabir Life Sciences & Research Product
Table 146. Kabir Life Sciences & Research Recent Development
Table 147. Dm Pharma Corporation Information
Table 148. Dm Pharma Description and Business Overview
Table 149. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 150. Dm Pharma Product
Table 151. Dm Pharma Recent Development
Table 152. China Zhongshan Pharm Corporation Information
Table 153. China Zhongshan Pharm Description and Business Overview
Table 154. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 155. China Zhongshan Pharm Product
Table 156. China Zhongshan Pharm Recent Development
Table 157. Weight Loss Drugs Market Trends
Table 158. Weight Loss Drugs Market Drivers
Table 159. Weight Loss Drugs Market Challenges
Table 160. Weight Loss Drugs Market Restraints
Table 161. Weight Loss Drugs Customers List
Table 162. Weight Loss Drugs Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Weight Loss Drugs Product Picture
Figure 2. Global Weight Loss Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Liauid Weight Loss Drugs Product Picture
Figure 4. Tablets Weight Loss Drugs Product Picture
Figure 5. Global Weight Loss Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. Weight-reducing Aid
Figure 7. Other
Figure 8. Weight Loss Drugs Report Years Considered
Figure 9. Global Weight Loss Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Weight Loss Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Weight Loss Drugs Sales 2016-2027 (K Tablets)
Figure 12. Global Weight Loss Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Weight Loss Drugs Sales Market Share by Region (2016-2021)
Figure 14. Global Weight Loss Drugs Sales Market Share by Region in 2020
Figure 15. Global Weight Loss Drugs Revenue Market Share by Region (2016-2021)
Figure 16. Global Weight Loss Drugs Revenue Market Share by Region in 2020
Figure 17. Global Weight Loss Drugs Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Drugs Revenue in 2020
Figure 19. Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Weight Loss Drugs Sales Market Share by Type (2016-2021)
Figure 21. Global Weight Loss Drugs Sales Market Share by Type in 2020
Figure 22. Global Weight Loss Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Weight Loss Drugs Revenue Market Share by Type in 2020
Figure 24. Global Weight Loss Drugs Sales Market Share by Application (2016-2021)
Figure 25. Global Weight Loss Drugs Sales Market Share by Application in 2020
Figure 26. Global Weight Loss Drugs Revenue Market Share by Application (2016-2021)
Figure 27. Global Weight Loss Drugs Revenue Market Share by Application in 2020
Figure 28. Japan Weight Loss Drugs Sales Growth Rate 2016-2027 (K Tablets)
Figure 29. Japan Weight Loss Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. Japan Weight Loss Drugs Market Share in Global Market 2016-2027
Figure 31. Japan 5 and 10 Largest Weight Loss Drugs Players Market Share by Revenue in Weight Loss Drugs in 2020
Figure 32. Japan Weight Loss Drugs Revenue Share by Type (2016-2021)
Figure 33. Japan Weight Loss Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Japan Weight Loss Drugs Revenue Share by Application (2016-2021)
Figure 35. Japan Weight Loss Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Weight Loss Drugs Sales Growth Rate 2016-2021 (K Tablets)
Figure 37. North America Weight Loss Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Weight Loss Drugs Sales Market Share by Country in 2020
Figure 39. North America Weight Loss Drugs Revenue Market Share by Country in 2020
Figure 40. U.S. Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 41. U.S. Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 43. Canada Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Weight Loss Drugs Sales Growth Rate 2016-2021 (K Tablets)
Figure 45. Europe Weight Loss Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Weight Loss Drugs Sales Market Share by Country in 2020
Figure 47. Europe Weight Loss Drugs Revenue Market Share by Country in 2020
Figure 48. Germany Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 49. Germany Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 51. France Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 53. U.K. Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 55. Italy Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 57. Russia Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Weight Loss Drugs Sales Growth Rate 2016-2021 (K Tablets)
Figure 59. Asia Pacific Weight Loss Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Weight Loss Drugs Sales Market Share by Region in 2020
Figure 61. Asia Pacific Weight Loss Drugs Revenue Market Share by Region in 2020
Figure 62. China Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 63. China Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 65. Japan Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 67. South Korea Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 69. India Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Weight Loss Drugs Sales Growth Rate (2016-2021) (K Tablets)
Figure 71. Australia Weight Loss Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Fig
  • Global and China Staphylococcal Infection Drugs Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 132
    Staphylococcal Infection Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Staphylococcal Infection Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on......
  • Global and China Equine Supplement Products Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Equine Supplement Products market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Equine Supplement Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Equ......
  • Global and China Postoperative Pain Therapeutics Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 147
    Postoperative Pain Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Pain Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses ......
  • Global and China Translational Regenerative Medicine Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Translational Regenerative Medicine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report ......
  • Global and Japan Haemophilia Treatment Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Haemophilia Treatment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Haemophilia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Haemophilia T......
  • Global and China Bispecific Antibodies for Cancer Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 135
    Bispecific Antibodies for Cancer market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Antibodies for Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuse......
  • Global and United States Embolization Microsphere Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 132
    Embolization Microsphere market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Embolization Microsphere market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the......
  • Global and Japan Antiretroviral Drug Market Size, Status and Forecast 2021-2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 97
    Global Antiretroviral Drug Scope and Market Size Antiretroviral Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type......
  • Global and Japan Chemotherapy Drug Market Size, Status and Forecast 2021-2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 95
    Global Chemotherapy Drug Scope and Market Size Chemotherapy Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs